⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
Recover Investment Losses: Class Action Initiated Against MoonLake Immunotherapeutics (MLTX)
accessnewswire.com
MLTX
MLTX LAWSUIT ALERT: Levi & Korsinsky Notifies MoonLake Immunotherapeutics Investors - Lead Plaintiff Deadline December 15, 2025
accessnewswire.com
MLTX
Class Action Filed Against MoonLake Immunotherapeutics (MLTX) Over Securities Violations - Contact Levi & Korsinsky Today
accessnewswire.com
MLTX
MoonLake Immunotherapeutics (MLTX) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before December 15, 2025
accessnewswire.com
MLTX
New SueWallSt Podcast Covers MoonLake Immunotherapeutics (MLTX) Class Action
accessnewswire.com
MLTX
Levi & Korsinsky Urges MoonLake Immunotherapeutics (MLTX) Shareholders to Act Before Lead Plaintiff Deadline December 15, 2025
accessnewswire.com
MLTX
MLTX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that MoonLake Immunotherapeutics Stockholders Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
MLTX
Pomerantz LLP Informs Investors of Class Action Against MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
Contact Levi & Korsinsky by December 15, 2025 to Join Class Action Against MoonLake Immunotherapeutics (MLTX)
accessnewswire.com
MLTX
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit
prnewswire.com
MLTX